Highlights and Quick Summary
- Annual Free Cash Flow Margin for 2021 was -11282.02% (a 112.9% increase from previous year)
- Annual Free Cash Flow Margin for 2020 was -5299.11% (a 82.44% increase from previous year)
- Annual Free Cash Flow Margin for 2019 was -2904.64% (a -23.45% decrease from previous year)
- Twelve month Free Cash Flow Margin ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Twelve month trailing Free Cash Flow Margin decreased by NaN% year-over-year
Trailing Free Cash Flow Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 0.0% | 0.0% | -5807.25% | 0.0% |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Margin of Atreca, Inc.
Most recent Free Cash Flow Marginof BCEL including historical data for past 10 years.Interactive Chart of Free Cash Flow Margin of Atreca, Inc.
Atreca, Inc. Free Cash Flow Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | -11282.02% |
| 2020 | – | – | – | – | -5299.11% |
| 2019 | – | – | – | – | -2904.64% |
| 2018 | – | – | – | – | -3794.38% |
| 2017 | – | – | – | – | -1459.92% |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology